In Reply: Efficacy and Safety of Carmustine Wafer Implantation After Ventricular Opening in Glioblastomas, Isocitrate Dehydrogenase-Wildtype, in Adults

Neurosurgery. 2024 Jul 1;95(1):e28. doi: 10.1227/neu.0000000000002985. Epub 2024 May 7.

Authors

Alexandre Roux^{1

2}, Angela Elia^{1

2}, Marc Zanello^{1

2}, Johan Pallud^{1

2}

Affiliations

¹ Service de Neurochirurgie, GHU Paris Psychiatrie et Neurosciences, Site Sainte Anne, Paris , France.
² Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Paris , France.

PMID: 38712956
DOI: 10.1227/neu.0000000000002985

No abstract available

Publication types

Letter

MeSH terms

Adult
Antineoplastic Agents, Alkylating* / administration & dosage
Antineoplastic Agents, Alkylating* / adverse effects
Brain Neoplasms* / surgery
Carmustine* / administration & dosage
Glioblastoma* / drug therapy
Glioblastoma* / surgery
Humans
Isocitrate Dehydrogenase* / genetics

Substances

Carmustine
Isocitrate Dehydrogenase
Antineoplastic Agents, Alkylating